SONOSCAPE(SZ:300633) Sou Hu Cai Jing·2025-10-24 14:21Core Viewpoint - The stock of Kaili Medical (300633) has shown a slight increase of 2.04% on October 24, 2025, closing at 33.56 yuan, despite a net outflow of major funds [1][2]. Financial Performance - For the first half of 2025, Kaili Medical reported a main revenue of 964 million yuan, a year-on-year decrease of 4.78%, and a net profit attributable to shareholders of 47.03 million yuan, down 72.43% year-on-year [3]. - The company's second-quarter results showed a main revenue of 534 million yuan, a slight increase of 0.17% year-on-year, but a net profit decline of 44.65% year-on-year [3]. Market Position - Kaili Medical's total market capitalization is 14.522 billion yuan, which is higher than the industry average of 11.653 billion yuan, ranking 21st out of 124 in the medical device industry [3]. - The company's price-to-earnings ratio (P/E) stands at 154.39, significantly higher than the industry average of 94.97, ranking 79th out of 124 [3]. Investment Sentiment - In the last 90 days, 22 institutions have rated the stock, with 14 buy ratings and 8 hold ratings, indicating a generally positive outlook [4]. - The average target price set by institutions over the past 90 days is 41.63 yuan, suggesting potential upside from the current price [4].